← FDA Drug Approvals (Drugs@FDA)

NEOSTIGMINE METHYLSULFATE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: AM REGENT · Approved 2018-05-04

Drug application

FDA Application #

ANDA209182

Application type

Abbreviated New Drug Application (Generic)

Brand name

NEOSTIGMINE METHYLSULFATE

Generic name

Neostigmine Methylsulfate

Active ingredients

NEOSTIGMINE METHYLSULFATE

Dosage form

SOLUTION

Route

INTRAVENOUS

Marketing status

Discontinued

Sponsor

AM REGENT

First approval

2018-05-04

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown